Randomised Open Label Study of Insulin Degludec Versus Insulin Glargine U100 in Ramadan
Clinical trial NCT03349840 · TERMINATED
Trial details
- NCT number
- NCT03349840
- Sponsor
- Weill Cornell Medical College in Qatar
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-07
- Primary completion
- 2018-08-03
- Enrollment
- 273
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.